This is implicit in the cognitive and electrophysiological intermediate phenotype results.80 The majority of genes thus far identified as likely to confer susceptibility to schizophrenia impact in diverse ways on the development, activity, plasticity, and composition of various synaptic components, eg, axon terminals, cytoplasmic vesicular transport, dendritic structure, and function. For example, the authors of a Inhibitors,research,lifescience,medical recent comprehensive review of the molecular origins of schizophrenia10 identified 12 “good bet” candidate risk genes, while readily acknowledging the subjective and most likely transient

nature of their list. Caveats notwithstanding, the authors’ stringent criteria included the following: Strength of evidence for association with schizophrenia, based on sample Inhibitors,research,lifescience,medical size and number of replications in at least three positive independent studies. Linkage to a gene locus associated with schizophrenia, based on data from two recent meta-analyses.87,88 Biological plausibility, based on evidence of altered function and expression in vivo or in vitro.89-91 Evidence of altered expression in schizophrenia brain, based on measures of mRNA or protein,

Inhibitors,research,lifescience,medical or relative expression of isoforms or alleles.92-102 The following candidate genes were particularly highlighted: COMT (22q11); DTNBP1 (6p22); NRG1 (selleck inhibitor 8p12-21); RGS4 (1q21-22); GRM3 (7q21-22); DISCI (1q42); and G72 (13q32-34). Importantly, with regards to discussion of intermediate Inhibitors,research,lifescience,medical phenotypes in schizophrenia, converging evidence to support the candidacy of the nominated genes derives from morphometric, histopathological, and animal experiment data, implicating hippocampal glutamatergic dysfunction,91 GABAergic (GABA, γ-aminobutyric acid), and glutamatergic abnormalities in the DLPFC,92-95 frontocortical dopaminergic inervation,89,90,96 Inhibitors,research,lifescience,medical and signal transmission.98 From this comes the suggestion

that schizophrenia may be viewed as a disorder associated with broad-based disruptions of cortical synaptic functions and perturbed synaptic plasticity on the microcircuit scale10,81-86,99 and as disruptions of high-order information processing on the neural systems scale.15,80 COMT Egan and colleagues89 studied abnormalities Rolziracetam of prefrontal cortical function in schizophrenia associated with the regulation of prefrontal dopamine, a neurotransmitter that modulates the response of prefrontal neurons during working memory. They examined the relationship of a common functional polymorphism (Val(108/158)Met) in the catechol-O-methyltransferase (COMT) gene, which accounts for a fourfold variation in enzyme activity and dopamine catabolism, with both prefrontally mediated cognition and prefrontal cortical physiology.